ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Past Conferences
  • ISPOR Europe 2025
  • Program
  • Program
  • Session
  • The Issue No One Talks About: Standardizing Adverse Event Inclusion in Economic Evaluations

    Sep 22, 2025, 16:24
  • Is It Really Time to Abandon Excel or Can R Generate Excel Models for HTA Submissions?

    Sep 22, 2025, 16:24
  • Can We Have It “Whole”? Barriers and Opportunities for Embracing a Whole Health Perspective in HEOR

    Sep 22, 2025, 16:24
  • Accelerating Patient Access to Innovations in Europe: Is It Possible to Integrate the JCA Into Diverse HTA systems?

    Sep 22, 2025, 16:24
  • Core Outcome Sets—A Key Enabler of Patient-Centered, System-Wide Efficiencies Linking Clinical Trials, Regulatory Processes, and Reimbursement Decisions?

    Sep 22, 2025, 16:24
  • EMA vs. JCA vs. HTA: Navigating Evidence Requirements and Simultaneous Interactions

    Sep 22, 2025, 16:24
  • Effectively Advocating for HEOR: Cross-Organization Experiences (A Women in HEOR Forum)

    Sep 22, 2025, 16:24
  • Competencies That Matter: Building Effective HEOR Capabilities for Medical Devices and Diagnostics

    Sep 22, 2025, 16:24
  • Swimming in the Sea of RWE Guidance: Debating a Path Forward

    Sep 22, 2025, 16:24
  • Joint Clinical Assessment (JCA) in Practice: Strengthening EU HTA Through CEE Expertise and Patient Perspectives

    Sep 22, 2025, 16:24
  • The Real-World Mosaic: Uniting Data to Illuminate the Patient Experience

    Sep 22, 2025, 16:24
  • Advancing Statistical Methods in Survival Analysis

    Sep 22, 2025, 16:24
  • Preferences in Frail and Older Patient Populations

    Sep 22, 2025, 16:24
  • Patient-Centric Approaches When Using Digital Health Technology in Drug Development

    Sep 22, 2025, 16:24
  • EU Pharmaceutical Package: Where Are We and Where Are We Going?

    Sep 22, 2025, 16:24
  • Data From Early Access Programs: Essential HTA Evidence or Misaligned Value Tool?

    Sep 22, 2025, 16:24
  • Beyond the Health Sector: Embedding Labor Market Effects and Productivity in HTA

    Sep 22, 2025, 16:24
  • The ECOnomiC Valuation of the Health Impacts of Climate Action (or Inaction): The ECO-CHICA Guidelines

    Sep 22, 2025, 16:24
  • Navigating a Maze of Indirect Treatment Comparisons: How to Ensure We Have Selected the Ideal Method for a Decision-Problem

    Sep 22, 2025, 16:24
  • Building Multi-Agent AI Systems to Reduce Subject Matter Expert Burden in Health Economics Research

    Sep 22, 2025, 16:24
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6 (current)
  • 7
  • 8
  • 9
  • 10
Quick Links

  • About ISPOR
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group